Table 1.
Distribution of current and cumulative prednisone-equivalent glucocorticoid (GC) dosage in patients with polymyalgia rheumatica
| Starting dose | 1 year | 2 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Current dose, mg/day* | |||||
| No. | 352 | 229 | 130 | 57 | 16 |
| Mean ± SD | 16.9 ± 7.1 | 5.9 ± 5.6 | 6.1 ± 7.6 | 7.2 ± 9.5 | 9.1 ± 14.1 |
| Median | 15.0 | 5.0 | 4.4 | 5.0 | 5.0 |
| Quartile 1, quartile 3 | 15.0, 20.0 | 2.8, 7.6 | 2.5, 7.0 | 3.0, 6.8 | 3.0, 9.1 |
| Range | 5.0–60.0 | 1.0–60.0 | 1.0–60.0 | 1.0–60.0 | 1.0–60.0 |
| Cumulative dose, grams† | |||||
| No. | 359 | 334 | 302 | 201 | 78 |
| Mean ± SD | 0.0 ± 0.0 | 2.9 ± 1.8 | 4.0 ± 3.5 | 6.3 ± 9.8 | 9.4 ± 25.1 |
| Median | 0.0 | 2.7 | 3.4 | 3.9 | 4.2 |
| Quartile 1, quartile 3 | 0.0, 0.0 | 1.9, 3.6 | 2.1, 5.4 | 2.1, 7.9 | 1.9, 8.4 |
| Range | 0.0–0.1 | 0.0–21.8 | 0.0–43.7 | 0.0–109.4 | 0.0–218.9 |
Among patients on GC at each time point.
Among all patients being followed, still under observation at each time point, including patients who are no longer on glucocorticoid therapy.